Stevie Nicks and Lindsey Buckingham are on speaking terms again, having recently appeared on the 'Song Exploder' podcast, ...

"Charles Barkley is going on the offense after seeing his weight rebound. The NBA Hall of Famer has signed on as GLP-1 ...

Join Joe Bart as he explores various gaming experiences and offers insights into philosophy while engaging with his community ...

The Purdue University Campaign Planning Committee hosted a pep rally Friday evening to celebrate the new “Victories and ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly and spawning a ...

See, LLY stock warrants your attention. Why? Because it offers monopoly-like high margins at a discounted price.

I go over 3 potential catalysts that could drive Eli Lilly's stock price up... or down. Read the full analysis here.

The company's multibillion-dollar investments in manufacturing in the U.S. are likely to be warmly welcomed by the Trump administration. Eli Lilly's management has already committed to taking action ...

Oct 6 (Reuters) - Eli Lilly (LLY.N), opens new tab will invest more than $1 billion in India in the coming years to boost manufacturing and supply through local drugmakers, the company said on Monday, ...

Mounjaro and Zepbound have helped boost the company's market cap. New data indicate these drugs do more than just help patients lose weight, contributing to potentially lowering risks to hearts and ...

Eli Lilly and Company (NYSE:LLY) shares are trading lower Friday, among other GLP-1 drug manufacturers, following President Donald Trump‘s comments that fat-loss drugs will be a lot lower in price.